Matthew B Palmer, MD, PhD

Associate Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Director, Electron Microscopy, Hospital of the University of Pennsylvania
Director, Renal Pathology, Hospital of the University of Pennsylvania
Staff, Surgical Pathology, Hospital of the University of Pennsylvania
Department: Pathology and Laboratory Medicine
Contact information
Hospital of the University of Pennsylvania
6 Founders
3400 Spruce Street
Philadelphia, PA 19104
6 Founders
3400 Spruce Street
Philadelphia, PA 19104
Education:
B.S. (Zoology and Russian)
Brigham Young University, 1998.
Ph.D. (Biochemistry, Cell, and Developmental Biology)
Emory University, 2008.
M.D. (Doctor of Medicine)
Emory University School of Medicine, 2008.
Permanent linkB.S. (Zoology and Russian)
Brigham Young University, 1998.
Ph.D. (Biochemistry, Cell, and Developmental Biology)
Emory University, 2008.
M.D. (Doctor of Medicine)
Emory University School of Medicine, 2008.
Selected Publications
Dhanunjay Mukhi, Lakshmi Prasanna Kolligundla, Tomohito Doke, Magaiver Andrade- Silva, Hongbo Liu, Matthew Palmer, Katalin Susztak : The actin and microtubule network regulator WHAMM is identified as a key kidney disease risk gene. Cell Reports 44(4), April 2025.Aguila T, Madan R, Palmer MB, Derk CT: Zebra Bodies in Kidney Biopsy: Drug-Induced Phospholipidosis in a Patient With Systemic Lupus Erythematosus. Journal of Rheumatology March 2025.
Liu H, Abedini A, Ha E, Ma Z, Sheng X, Dumoulin B, Qiu C, Aranyi T, Li S, Dittrich N, Chen HC, Tao R, Tarng DC, Hsieh FJ, Chen SA, Yang SF, Lee MY, Kwok PY, Wu JY, Chen CH, Khan A, Limdi NA, Wei WQ, Walunas TL, Karlson EW, Kenny EE, Luo Y, Kottyan L, Connolly JJ, Jarvik GP, Weng C, Shang N, Cole JB, Mercader JM, Mandla R, Majarian TD, Florez JC, Haas ME, Lotta LA; Regeneron Genetics Center‡; GHS-RGC DiscovEHR Collaboration§; Drivas TG; Penn Medicine BioBank¶; Vy HMT, Nadkarni GN, Wiley LK, Wilson MP, Gignoux CR, Rasheed H, Thomas LF, Åsvold BO, Brumpton BM, Hallan SI, Hveem K, Zheng J, Hellwege JN, Zawistowski M, Zöllner S, Franceschini N, Hu H, Zhou J, Kiryluk K, Ritchie MD, Palmer M, Edwards TL, Voight BF, Hung AM, Susztak K: Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants. Science 387(6734): 4753, February 2025.
Sato S, Miwa T, Gullipalli D, Golla M, Mohammadyari E, Zhou L, Palmer M, Song WC.: Improved therapeutic efficacy of a bifunctional anti-C5 mAb-FH SCR1-5 fusion protein over anti-C5 mAb in an accelerated mouse model of C3 glomerulopathy. Immunohorizons 9(3), January 2025.
Abedini A, Levinsohn J, Klötzer KA, Dumoulin B, Ma Z, Frederick J, Dhillon P, Balzer MS, Shrestha R, Liu H, Vitale S, Bergeson AM, Devalaraja-Narashimha K, Grandi P, Bhattacharyya T, Hu E, Pullen SS, Boustany-Kari CM, Guarnieri P, Karihaloo A, Traum D, Yan H, Coleman K, Palmer M, Sarov-Blat L, Morton L, Hunter CA, Kaestner KH, Li M, Susztak K.: Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression. Nature Genetics 56(8): 1712-1724, August 2024.
Allaf ME, Kim SE, Master V, McDermott DF, Harshman LC, Cole SM, Drake CG, Signoretti S, Akgul M, Baniak N, Li-Ning E, Palmer MB, Emamekhoo H, Adra N, Kaimakliotis H, Ged Y, Pierorazio PM, Abel EJ, Bilen MA, Ogan K, Moon HH, Ramaswamy KA, Singer EA, Mayer TM, Lohrey J, Margulis V, Gills J, Delacroix SE, Waples MJ, James AC, Wang P, Choueiri T, Michaelson MD, Kapoor A, Heng DY, Shuch B, Leibovich BC, Lara PN, Manola J, Maskens D, Battle D, Uzzo R, Bratslavsky G, Haas NB, Carducci MA.: Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study. Lancet Oncology 25(8): 1038-1052, August 2024.
Yan Y, Liu H, Abedini A, Sheng X, Palmer M, Li H, Susztak K.: Unraveling the epigenetic code: human kidney DNA methylation and chromatin dynamics in renal disease development. Nature Communications 15(1): 873, January 2024.
Murphy JD, Caza TN, Cassol CA, Storey A, Ambruzs JM, Boils C, Walker PD, Sharma S, Messias N, Hennigar R, Andeen NK, VanBeek C, Palmer M, Sankar L, Sanghi P, Dinesh K, Dicker L, Urisman A, Larsen CP.: Clinicopathologic Features of Antibrush Border Antibody Disease. Kidney International Reports 9(2): 370-382, November 2023.
Matthew B Palmer; Virginie Royal; J. Charles Jennette; Abigail R. Smith; Qian Liu; Josephine M. Ambruzs; Nicole K. Andeen; Vivette D. D’Agati; Agnes B. Fogo; Joseph Gaut; Rasheed A. Gbadegesin; Larry A. Greenbaum; Jean Hou; Margaret E Helmuth; Richard A. Lafayette; Helen Liapis; Bruce Robinson; Michael B. Stokes; Katherine Twombley; Hong Yin; Cynthia C. Nast; for the CureGN Consortium: Cure Glomerulonephropathy Pathology Classification and Core Scoring Criteria, Reproducibility, and Clinicopathologic Correlations. Glomerular Diseases 3(1): 248-257, October 2023.
Nova-Camacho LM, Acosta AM, Trpkov K, Sangoi AR, Pierre A, Chou A, Yilmaz A, Morini A, Rodrigues Â, Fletcher CDM, Perez-Montiel D, Maclean F, Contreras F, Queipo FJ, Muñiz Unamunzaga G, Mesa H, de Torres I, Ruiz I, Alvarado-Cabrero I, Lobo J, Schwartz L, Cheng L, Akgul M, García-Martos M, Palmer MB, Aron M, Raspollini MR, Manrique Celada M, Hwang M, Idrees MT, Rioux-Leclercq N, Zalles N, Vergara N, Lal P, Wobker S, Kammerer-Jacquet SF, Prendeville S, Tilmant T, Ulbright TM, Verkarre V, Collins K, Williamson SR, Panizo A.: Metastatic solid tumors to the testis: a clinicopathologic evaluation of 157 cases from an international collaboration. Human Pathology 139: 37-46, September 2023.